Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Bullboard Posts
Comment by BigShoes13on Feb 26, 2014 12:12am
133 Views
Post# 22251305

RE:RE:RE:RE:US portion to follow

RE:RE:RE:RE:US portion to followwj What is your point? Read between what lines??? The company announces a big PP for over $5.0 million at $.16. It is unable to fill it so it announces a smaller one at $0.13. They are able to get $1.2 from investors but not $5 million. It is quite simple. There are no lines to read between. There are a lot of posts on this Board about reading between the lines. What that really means is that you don't have a clue what is happening but are "hoping" something is happening. As for the US listing, are you serious? We have a market cap of $15 million. Are you really able to fool yourself that much? The whole talk of a US listing is such a waste of time. A diversion in my opinion. Yes it could happen but it is a long, long, long way away. So long that it is not even worth talking about now.
Bullboard Posts